tiprankstipranks
Percheron Therapeutics (AU:PER)
ASX:PER
Australian Market

Percheron Therapeutics (PER) Financial Statements

Compare
12 Followers

Percheron Therapeutics Financial Overview

Percheron Therapeutics's market cap is currently $15.22M. The company's EPS TTM is AU$-0.017; its P/E ratio is ―; Percheron Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -7.61M$ -8.68M$ -6.67M$ -3.58M$ -2.62M
EBITDA$ -7.52M$ -8.58M$ -6.56M$ -3.58M$ -2.61M
Net Income$ -5.81M$ -8.06M$ -5.91M$ -2.94M$ -2.33M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 22.44M$ 7.00M$ 5.35M$ 3.70M$ 4.80M
Total Debt$ 227.40K$ 306.85K$ 135.26K$ 0.00$ 0.00
Net Debt$ -19.01M$ -5.71M$ -3.92M$ -2.90M$ -4.30M
Total Liabilities$ 1.30M$ 1.27M$ 821.23K$ 888.84K$ 580.86K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -7.81M$ -5.84M$ -3.96M$ -2.93M$ -2.30M
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

Percheron Therapeutics Earnings and Revenue History

Percheron Therapeutics Debt to Assets

Percheron Therapeutics Cash Flow

Percheron Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis